CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
Yong Won Choi, Jin-Hyuk Choi
Korean J Intern Med. 2017;32(3):422-428.   Published online 2017 March 30    DOI: https://doi.org/10.3904/kjim.2016.190

Excel Download

Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
The Korean Journal of Internal Medicine. 2017;32(3):422-428   Crossref logo
Link1 Link2

Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis
Thoracic Cancer. 2011;2(3):101-108   Crossref logo
Link1

First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation; Positive Non-small Cell Lung Cancer Patients
Journal of Thoracic Oncology. 2008;3(6):S143-S145   Crossref logo
Link1 Link2

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation
Thoracic Cancer. 2016;7(5):614-618   Crossref logo
Link1

Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib
Lung Cancer. 2013;82(2):305-312   Crossref logo
Link1 Link2

Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
Open Medicine. 2016;11(1):   Crossref logo
Link1

Epidermal growth factor receptor (EGFR) in non small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:2   Crossref logo
Link1 Link2

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
Yearbook of Oncology. 2011;2011:220-221   Crossref logo
Link1 Link2

22 Epidermal growth factor receptor (EGFR) mutation testing in non small cell lung cancer – the New Cross Hospital experience
Lung Cancer. 2013;79:S8   Crossref logo
Link1 Link2

71: Audit of the epidermal growth factor tyrosine kinase (EGFR) and anaplastic lymphoma kinase (ALK) mutation request pathway in non-squamous non-small cell lung cancer (NSCLC) in Kent
Lung Cancer. 2015;87:S28   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.